Joben Bio-Medical Co Ltd

Joben Bio-Medical Co Ltd


Company description

The Company dedicates itself in CO2 SFE technology, developing new botanical drugs, local Chinese herbal medicine, health food, and anti-aging products for the aesthetic medicine. By using our core technologies on natural Chinese herbal medicine, Joben Bio-Medical has successfully developed the new botanic drug JBM-TC4 (patent protection pending), which was approved by U.S. FDA-Phase II for clinical trial in March 2013, and approved by TFDA for phase II clinical trial in May. When the new botanic drug JBM-TC4 is successfully developed, it will offer cancer patients all over the world more options for treating cancer effectively. A botanic drug with compound ingredients can be used with the small molecule drug of a single ingredient, and this will be a major trend for the integrated treatment of cancer in the future, for it not only can assist and increase the anti-cancer treatment, but also reduce the side effects brought about by the small molecule drug of a single ingredient. This is very significant, for it increases the living quality of the cancer patients by reducing the side effects of treatment.

Quick facts

Sales markets Western Europe, Eastern Europe, Middle East, Asia, Australia, North America, Africa, Central/South America

Joben Bio-Medical Co Ltd

Contact information




View all contact information